Bill Snyder

Richard Caprioli and mass spectrometer
March 3, 2014

Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells

Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years.

By Bill Snyder
February 27, 2014

ASPET honors Lindsley’s pharmacology research

Vanderbilt University’s Craig Lindsley, Ph.D., has won the 2014 John J. Abel Award in Pharmacology for young investigators from the American Society for Pharmacology and Experimental Therapeutics (ASPET).

By Bill Snyder
February 20, 2014

Event set to reveal wonders, mysteries of the brain

“Brain Blast,” a half day of free, hands-on activities for children and adults, will be held from 9 a.m. to 1 p.m., Saturday, March 1, at Vanderbilt Health One Hundred Oaks, 719 Thompson Lane.

By Bill Snyder
February 20, 2014

Noted clinical pharmacologist Kim to speak

Richard Kim, M.D., former professor of Medicine and clinical pharmacologist at Vanderbilt, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology at 8 a.m. Thursday, Feb. 27, in 208 Light Hall.

By Bill Snyder
microscope
February 13, 2014

Major grant creates clinical research network

Vanderbilt University Medical Center has received an 18-month, $6.9 million award to set up a Clinical Data Research Network (CDRN) that can reach millions of patients and speed the translation of research findings into clinical practice.

By Bill Snyder
February 6, 2014

Discovery Lecture sheds light on properties of motion

Ron Vale, Ph.D., co-discoverer of the molecular “motor” kinesin, spent the first 10 minutes of his Flexner Discovery Lecture last week talking not about science, but about science communication.

By Bill Snyder
February 6, 2014

Antioxidants promising for rare disorder

The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development.
By Bill Snyder
February 5, 2014

Discovery may pave way for RSV vaccine

Vanderbilt University scientists have contributed to a major finding, reported this week in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.
By Bill Snyder
January 30, 2014

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).
By Bill Snyder
January 24, 2014

Nine faculty honored with endowed chairs

Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.
By Bill Snyder
January 23, 2014

Autism Speaks grant boosts Rett syndrome research

Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome.
By Bill Snyder
January 23, 2014

UCSF’s Vale set to explore mechanisms of biological motility

Ron Vale, Ph.D., Lasker Award winner and co-discoverer of the molecular “motor” kinesin, will give the next Flexner Discovery Lecture at 4 p.m. on Thursday, Jan. 30, in 208 Light Hall.
By Bill Snyder
1 … 98 99 100 101 102 … 115